|4Aug 14, 5:49 PM ET

Atadja Peter 4

4 · Onconova Therapeutics, Inc. · Filed Aug 14, 2023

Insider Transaction Report

Form 4
Period: 2023-08-10
Atadja Peter
Director
Transactions
  • Award

    Stock Option (right to purchase)

    2023-08-10+66,46866,468 total
    Exercise: $1.02From: 2024-08-10Exp: 2033-08-10Common Stock (66,468 underlying)
Footnotes (1)
  • [F1]These options vest 100% on the first anniversary of the grant date.

Documents

1 file
  • 4
    form4-08142023_090853.xmlPrimary